These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Effects of urapidil on neurotransmitter release in CNS tissue in vitro. Author: Jackisch R, Kasakov L, Feuerstein TJ, Hertting G. Journal: Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):5-24. PubMed ID: 2883943. Abstract: The effects of the antihypertensive drug urapidil on the electrically evoked release of [3H]-noradrenaline (NA) in rabbit cortex slices, of [3H]-acetylcholine (ACh) and [3H]-5-hydroxytryptamine (5-HT) in rabbit hippocampus slices, and of [3H]-ACh and [3H]-dopamine (DA) in rabbit caudate nucleus slices were investigated. Urapidil significantly increased basal tritium outflow in slices preincubated with [3H]-NA and showed weak alpha 2-adrenoceptor antagonism on the evoked NA-release. The pA2-value of urapidil against the inhibitory effect of the alpha 2-agonist clonidine was about 6.3. In contrast to phentolamine, urapidil exhibited no partial agonistic properties at alpha 2-adrenoceptors in this model when stimulation was performed at low frequency and in the absence of cocaine. Neither the evoked ACh- nor 5-HT-release in hippocampal slices were affected by urapidil in concentrations up to 10 microM, but basal tritium outflow was significantly enhanced from slices preincubated with [3H]-5-HT. In caudate nucleus slices urapidil (greater than 1 microM) significantly facilitated both the evoked ACh- and DA-release, effects which were enhanced by the DA-reuptake inhibitor nomifensine. The effects of the D2-dopamine receptor selective agonist LY 171555 and the D2-receptor antagonist domperidone on the evoked DA-release were reduced by 1 microM urapidil. In addition, urapidil (10 microM) increased basal tritium outflow from slices preincubated with [3H]-DA. It is concluded that the antihypertensive effect of urapidil is not mediated by presynaptic actions affecting NA- or 5-HT-release within the CNS. Whether an increased dopaminergic or cholinergic transmission following the observed enhancement of DA- or ACh-release (due to a weak D2-receptor antagonism) is involved, remains to be further elucidated.[Abstract] [Full Text] [Related] [New Search]